Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 80

Similar articles for PubMed (Select 22734757)

1.

Improved tumor contrast achieved by single time point dual-reporter fluorescence imaging.

Tichauer KM, Samkoe KS, Sexton KJ, Gunn JR, Hasan T, Pogue BW.

J Biomed Opt. 2012 Jun;17(6):066001. doi: 10.1117/1.JBO.17.6.066001.

2.

The antiangiogenic activity in xenograft models of brivanib, a dual inhibitor of vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1 kinases.

Bhide RS, Lombardo LJ, Hunt JT, Cai ZW, Barrish JC, Galbraith S, Jeyaseelan R Sr, Mortillo S, Wautlet BS, Krishnan B, Kukral D, Malone H, Lewin AC, Henley BJ, Fargnoli J.

Mol Cancer Ther. 2010 Feb;9(2):369-78. doi: 10.1158/1535-7163.MCT-09-0472. Epub 2010 Jan 26.

3.

In vivo quantification of tumor receptor binding potential with dual-reporter molecular imaging.

Tichauer KM, Samkoe KS, Sexton KJ, Hextrum SK, Yang HH, Klubben WS, Gunn JR, Hasan T, Pogue BW.

Mol Imaging Biol. 2012 Oct;14(5):584-92. doi: 10.1007/s11307-011-0534-y.

4.

Comparing implementations of magnetic-resonance-guided fluorescence molecular tomography for diagnostic classification of brain tumors.

Davis SC, Samkoe KS, O'Hara JA, Gibbs-Strauss SL, Paulsen KD, Pogue BW.

J Biomed Opt. 2010 Sep-Oct;15(5):051602. doi: 10.1117/1.3483902.

5.

Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell dissemination.

Festuccia C, Angelucci A, Gravina GL, Biordi L, Millimaggi D, Muzi P, Vicentini C, Bologna M.

Thromb Haemost. 2005 May;93(5):964-75.

PMID:
15886816
6.

Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts.

Ke S, Wen X, Gurfinkel M, Charnsangavej C, Wallace S, Sevick-Muraca EM, Li C.

Cancer Res. 2003 Nov 15;63(22):7870-5.

7.

Proteasome inhibition blocks ligand-induced dynamic processing and internalization of epidermal growth factor receptor via altered receptor ubiquitination and phosphorylation.

Kesarwala AH, Samrakandi MM, Piwnica-Worms D.

Cancer Res. 2009 Feb 1;69(3):976-83. doi: 10.1158/0008-5472.CAN-08-2938. Epub 2009 Jan 27.

9.

Development of a new reporter gene system--dsRed/xanthine phosphoribosyltransferase-xanthine for molecular imaging of processes behind the intact blood-brain barrier.

Doubrovin M, Ponomarev V, Serganova I, Soghomonian S, Myagawa T, Beresten T, Ageyeva L, Sadelain M, Koutcher J, Blasberg RG, Tjuvajev JG.

Mol Imaging. 2003 Apr;2(2):93-112.

PMID:
12964307
10.

Use of fluorescent labeled anti-epidermal growth factor receptor antibody to image head and neck squamous cell carcinoma xenografts.

Rosenthal EL, Kulbersh BD, King T, Chaudhuri TR, Zinn KR.

Mol Cancer Ther. 2007 Apr;6(4):1230-8.

11.

Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer.

Sampath L, Kwon S, Ke S, Wang W, Schiff R, Mawad ME, Sevick-Muraca EM.

J Nucl Med. 2007 Sep;48(9):1501-10.

12.

Imaging epidermal growth factor receptor expression in vivo: pharmacokinetic and biodistribution characterization of a bioconjugated quantum dot nanoprobe.

Diagaradjane P, Orenstein-Cardona JM, Colón-Casasnovas NE, Deorukhkar A, Shentu S, Kuno N, Schwartz DL, Gelovani JG, Krishnan S.

Clin Cancer Res. 2008 Feb 1;14(3):731-41. doi: 10.1158/1078-0432.CCR-07-1958.

13.

Narrow band imaging of squamous cell carcinoma tumors using topically delivered anti-EGFR antibody conjugated gold nanorods.

Puvanakrishnan P, Diagaradjane P, Kazmi SM, Dunn AK, Krishnan S, Tunnell JW.

Lasers Surg Med. 2012 Apr;44(4):310-7. doi: 10.1002/lsm.22019. Epub 2012 Mar 13.

PMID:
22415634
14.

In vivo molecular imaging to diagnose and subtype tumors through receptor-targeted optically labeled monoclonal antibodies.

Koyama Y, Barrett T, Hama Y, Ravizzini G, Choyke PL, Kobayashi H.

Neoplasia. 2007 Dec;9(12):1021-9.

15.

EGFR targeted fluorescence imaging in gliomas.

Poptani H.

Acad Radiol. 2010 Jan;17(1):1-2. doi: 10.1016/j.acra.2009.10.025. No abstract available.

PMID:
19969252
16.

Optical molecular imaging of epidermal growth factor receptor expression to improve detection of oral neoplasia.

Nitin N, Rosbach KJ, El-Naggar A, Williams M, Gillenwater A, Richards-Kortum RR.

Neoplasia. 2009 Jun;11(6):542-51.

17.

Decorin evokes protracted internalization and degradation of the epidermal growth factor receptor via caveolar endocytosis.

Zhu JX, Goldoni S, Bix G, Owens RT, McQuillan DJ, Reed CC, Iozzo RV.

J Biol Chem. 2005 Sep 16;280(37):32468-79. Epub 2005 Jul 1.

18.

AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.

Traxler P, Allegrini PR, Brandt R, Brueggen J, Cozens R, Fabbro D, Grosios K, Lane HA, McSheehy P, Mestan J, Meyer T, Tang C, Wartmann M, Wood J, Caravatti G.

Cancer Res. 2004 Jul 15;64(14):4931-41.

19.

Cy5.5-labeled Affibody molecule for near-infrared fluorescent optical imaging of epidermal growth factor receptor positive tumors.

Miao Z, Ren G, Liu H, Jiang L, Cheng Z.

J Biomed Opt. 2010 May-Jun;15(3):036007. doi: 10.1117/1.3432738.

PMID:
20615009
20.

Role of beta-arrestin 1 in the metastatic progression of colorectal cancer.

Buchanan FG, Gorden DL, Matta P, Shi Q, Matrisian LM, DuBois RN.

Proc Natl Acad Sci U S A. 2006 Jan 31;103(5):1492-7. Epub 2006 Jan 23.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk